We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
S100A8/A9 as a prognostic biomarker with causal effects for post-acute myocardial infarction heart failure.
- Authors
Ma, Jie; Li, Yang; Li, Ping; Yang, Xinying; Zhu, Shuolin; Ma, Ke; Gao, Fei; Gao, Hai; Zhang, Hui; Ma, Xin-liang; Du, Jie; Li, Yulin
- Abstract
Heart failure is the prevalent complication of acute myocardial infarction. We aim to identify a biomarker for heart failure post-acute myocardial infarction. This observational study includes 1062 and 1043 patients with acute myocardial infarction in the discovery and validation cohorts, respectively. The outcomes are in-hospital and long-term heart failure events. S100A8/A9 is screened out through proteomic analysis, and elevated circulating S100A8/A9 is independently associated with heart failure in discovery and validation cohorts. Furthermore, the predictive value of S100A8/A9 is superior to the traditional biomarkers, and the addition of S100A8/A9 improves the risk estimation using traditional risk factors. We finally report causal effect of S100A8/A9 on heart failure in three independent cohorts using Mendelian randomization approach. Here, we show that S100A8/A9 is a predictor and potentially causal medicator for heart failure post-acute myocardial infarction. Heart failure is the most prevalent complication of acute myocardial infarction. Here, the authors show that circulating S100A8/A9 is a robust predictor and potentially causal medicator for heart failure post-acute myocardial infarction, as such could serve as a promising drug target for cardioprotection.
- Subjects
HEART failure; MYOCARDIAL infarction; BIOMARKERS; DRUG target
- Publication
Nature Communications, 2024, Vol 15, Issue 1, p1
- ISSN
2041-1723
- Publication type
Article
- DOI
10.1038/s41467-024-46973-7